Antioxidant status of patients on peritoneal dialysis: Associations with inflammation and glycoxidative stress

Peritoneal Dialysis International

Volumn 29, Issue 1, 2009, Pages 89-101

  Sundl, Isabella ^a   Roob, Johannes M ^b   Meinitzer, Andreas ^b   Tiran, Beate ^b   Khoschsorur, Gholamali ^b   Haditsch, Bernd ^b   Holzer, Herwig ^b   Winklhofer Roob, Brigitte M ^a  

^a UNIVERSITY OF GRAZ   (Austria)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Advanced glycation end products; Ascorbate; Carotenoids; Interleukin 6; Malondialdehyde; Oxidative stress; Pentosidine

Indexed keywords

ASCORBIC ACID; BETA CRYPTOXANTHIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CAROTENOID; CHOLESTEROL; CREATININE; GLUCOSE; INTERLEUKIN 6; LYCOPENE; MALONALDEHYDE; PENTOSIDINE; RETINOL; TRIACYLGLYCEROL; UREA; XANTHOPHYLL; ZEAXANTHIN; ANTIOXIDANT; VITAMIN;

AGED; ARTICLE; BLOOD CHEMISTRY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIALYSATE LEVEL; DIETARY INTAKE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCOXIDATIVE STRESS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFLAMMATION; MALE; OXIDATIVE STRESS; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; ADULT; BLOOD; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG EFFECT; FOLLOW UP; GLYCOSYLATION; METABOLISM; METHODOLOGY; MIDDLE AGED; PHYSIOLOGY; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIOXIDANTS; ASCORBIC ACID; C-REACTIVE PROTEIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-SECTIONAL STUDIES; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; GLYCOSYLATION; HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OXIDATIVE STRESS; PERITONEAL DIALYSIS; PROGNOSIS; VITAMINS;

EID: 65349153074     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080902900113     Document Type: Article

References (62)

1. Boeschoten EW, Scrijver J, Krediet RT, Schreurs WHP Arisz L. Deficiencies of vitamins in CAPD patients: the effect of supplementation. Nephrol Dial Transplant 1988; 2:87-93.
2. Blumberg A, Hanck A, Sander G. Vitamin nutrition in patients on continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol 1983; 20:244-50.
3. Ozden M, Maral H, Akaydin D, Cetinalp P, Kalender B. Erythrocyte glutathione peroxidase activity, plasma malondialdehyde and erythrocyte glutathione levels in hemodialysis and CAPD patients. Clin Biochem 2002; 35: 269-71.
4. Tarng DC, Chen TW, Huang TP, Chen CL, Liu TY, Wei YH. Increased oxidative damage to peripheral blood leukocyte DNA in chronic peritoneal dialysis patients. J Am Soc Nephrol 2002; 13:1321-30.
5. Bonnefont-Rousselot D, Jaudon MC, Issad B, Cacoub P, Congy F, Jardel C, et al. Antioxidant status of elderly chronic renal patients treated by continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1997; 12: 1399-405.
6. Handelman GJ. Evaluation of oxidant stress in dialysis patients. Blood Purif 2000; 18:343-9.
7. Miyata T, Ueda Y, Horie K, Nangaku M, Tanaka S, van Ypersele de StrihouC, et al. Renal catabolism of advanced glycation end products: the fate of pentosidine. Kidney Int 1998; 53:416-22.
8. Miyata T, Horie K, Ueda Y, Fujita Y, Izuhara Y, Hirano H, et al. Advanced glycation and lipidoxidation of the peritoneal membrane: respective roles of serum and peritoneal fluid reactive carbonyl compounds. Kidney Int 2000; 58:425-35.
9. Qureshi AR, Alvestrand A, Divino-Filho JC, Gutierrez A, Heimburger O, Lindholm B, et al. Inflammation malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol 2002; 13(Suppl 1): S28-36.
10. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk aqd mortality in hemodialysis patients. Kidney Int 1909; 55: 648-58.
11. Suliman ME, Heimburger O, Barany P, Anderstam B, Pecoits-Filho R, Rodriguez Ayala E, et al. Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy. J Am Soc Nephrol 2003; 14:1614-22.
12. SchwedLer SB, Metzger T, SchinzeL R, Wanner C. Advanced glycation end products and mortality in hemodialysis patients. Kidney Int 2002; 62:301-10.
13. Gokal R, Mallick NP. Peritoneal dialysis. Lancet 1999; 353: 823-8.
14. Maiorca R, Sandrini S, Cancarini GC, Gaggia P, Chiappini R, Setti G, et al. Integration of peritoneal dialysis and transplantation programs. Perit Dial Int 1997; 17(Suppl 2):S170-4.
15. McGregor SJ, TopLey N, Jorres A, Speekenbrink AB, Gordon A, GahL dM, et al. Longitudinal evaluation of peritoneal macrophage function and activation during CAPD: maturity, cytokine synthesis and arachidonic acid metabolism. Kidney Int 1996; 49:525-33.
16. Li FK, Davenport A, Robson RL, Loetscher P, RothLein R, Williams JD, et al. Leukocyte migration across human peritoneal mesothelial cells is dependent on directed chemokine secretion and ICAM-1 expression. Kidney Int 1998; 54:2170-83.
17. TopLey N. Membrane Longevity in peritoneal dialysis: impact of infection and bio-incompatible solutions. Adv Ren Replace Ther 1998; 5:179-84.
18. Witowski J, Jorres A, Korybalska K, Ksiazek K, Wisniewska-ELnur J, Bender TO, et al. Glucose degradation products in peritoneal dialysis fluids: do they harm? Kidney Int Suppl 2003; 84:S148-51.
19. Miyata T, Devuyst O, Kurokawa K, van YperseLe de Strihou C. Toward better dialysis compatibility: advances in the biochemistry and pathophysiology of the peritoneal membranes. Kidney Int 2002; 61:375-86.
20. Erixon M, WiesLander A, Lindén T, Carlsson 0, Forsbäck G, Svensson E, et al. How to avoid glucose degradation products in peritoneal dialysis fLuids. Perit Dial Int 2006; 26: 490-7.
21. Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: a review. Diabetologia 2001; 44:129-46.
22. Roob JM, RaboLd L Hayn M, Khoschsorur G, Resch U, Holzer H, et al. Ex vivo Low-density Lipoprotein oxidizability and in vivo lipid peroxidation in patients on CAPD. Kidney Int Suppl 2001; 78:S128-36.
23. Janero DR. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 1990; 9:515-40.
24. Schmidt AM, Yan SD, Wautier JL, Stern D. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res 1999; 84:489-97.
25. Bierhaus A, Hofmann MA, Ziegler R, Nawroth PP. AGEs and their interaction with AGE-receptors in vascuLar disease and diabetes-mellitus. I. The AGE concept. Cardiovasc Res 1998; 37:586-600.
26. SchwedlerS, SchinzeL R, Vaith P, Wanner C. Inflammation and advanced glycation end products in uremia: simple coexistence, potentiation, or causal relationship? Kidney Int Suppl 2001; 78:S32-6.
27. Chew BP, Park JS. Carotenoid action on the immune response. J Nutr 2004; 134:257S-61S.
28. Krinsky NI. Actions of carotenoids in biological systems. Ann Rev Nutr 1993; 13:561-87.
29. Hughes DA. Effects of carotenoids on human immune function. Proc Nutr Soc 1999; 58:713-18.
30. Levine M, Wang Y, Rumsey SC. Analysis of ascorbic acid and dehydroascorbic acid in biological samples. Methods Enzymol 1999; 299:65-76.
31. Lykkesfeldt J, Loft S, Poulsen HE. Determination of ascorbic acid and dehydroascorbic acid in plasma by high-performance liquid chromatography with coulometric detection - are they reliable markers of oxidative stress? Anal Biochem 1995; 299:329-35.
32. Aebischer CP, SchierLe J, Schüep W. Simultaneous determination of retinol, tocopheroLs, carotene, Lycopene, and xanthophylls in plasma by means of reversed-phase high performance Liquid chromatography. Methods Enzymol 1999; 299:348-62.
33. Khoschsorur GA, Winklhofer-Roob BM, RabL H, Auer T, Peng Z, Schaur RJ. Evaluation of a sensitive HPLC method for the determination of malondialdehyde, and application of the method to different biological materials. Chromatographia 2000; 52:181-4.
34. Takahashi M, Kushida K, Kawana K, Ishihara C, Denda M, Inoue T, et al. Quantification of the cross-Link pentosidine in serum from normal and uremic subjects. Clin Chem 1993; 39:2162-5.
35. Winklhofer-Roob BM, PuhlH, Khoschsorur G, van't Hof MA, Esterbauer H, Shmerling DH. Enhanced resistance to oxidation of low density lipoproteins and decreased lipid peroxide formation during beta-caroten supplementation in cystic fibrosis. Free Radic Biol Med 1995; 18: 849-59.
36. Food and Nutrition Board. Vitamin C. In: Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium and Carotenoids. Washington, DC: National Academy Press; 2000:95-185.
37. Sullivan JF, Eisenstein AB, Mottola OM, MittaL AK. the effect of dialysis on plasma and tissue levels of vitamin C. Trans Am Soc Artif Intern Organs 1972; 18:277-82.
38. Shah GM, Ross EA, Sabo A, Pichon M, Bhagavan H, Reynolds RD. Ascorbic acid, supplements in patient receiVing chronic peritorneal dialysis. Am J Kidney Dis 1991; 18:84-90.
39. Shah GM, Ross EA, Sabo A, Pichon M, Reynolds RD, Bhagavan H. Effects of ascorbic acid and pyridoxine supplementation on oxalate metabolism in peritoneal dialysis patients. Am J Kidney Dis 1992; 20:42-9.
40. Mydlik M, Derzsiova K, Svac J, Dthopolcek P, Zemberova E. Peritoneal clearance and peritoneal transfer of oxalic acid, vitamin C, and vitamin B6 during continuous ambulatory peritoneal dialysis. Artif Organs 1998; 22:784-8.
41. Grandhee SK, Monnier VM. Mechanism of formation of the Maillard protein cross-link pentosidine. Glucose, fructose, and ascorbate as pentosidine precursors. J Biol Chem 1991; 266:11649-53.
42. SLight SH, Feather MS, Ortwerth BJ. GLycation of lens proteins by the oxidative products of ascorbic acid. Biochem Biophys Acta 1990; 1038:367-74.
43. Ortwerth BJ, Olesen PR. Glutathione inhibits the glycation and crosslinking of lens proteins by ascorbic acid. Exp Eye Res 1988; 47:737-50.
44. Weiss MF, Erhard P, Kader-Attia FA, Wu YC, Deoreo PB, Araki A, et al. Mechanisms for the formation of glycoxidation products in end-stage renal disease. Kidney Int 2000; 57: 2571-85.
45. Takahashi M, Oikawa M, Nagano A. Effect of age and menopause on serum concentrations of pentosidine, an advanced glycation end product. J Gerontol A Biol Sci Med Sci 2000; 55:137-40.
46. Sugiyama S, Miyata T, Ueda Y, Tanaka H, Maeda K, Kawashima S, et al. Plasma levels of pentosidine in diabetic patients: an advanced glycation end product. J Am Soc Nephrol 1998; 9:1681-8.
47. Bayazit AK, Vogt BA, Dell KM, Davis ID, Noyan A, Anarat A, et al. Effect of peritoneal dialysis prescription on pentosidine in children. Pediatr Nephrol 2003; 18:1049-54.
48. Makita Z, Radoff S, RayfieLd EJ, Yang Z, Skolnik E, Delaney V, et al. Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 1991; 325: 836-42.
49. Li PK, Cheng YL. Therapeutic options for preservation of residual renal function in patients on peritoneal dialysis. Perit Dial Int 2007; 27(SuppL 2):S158-63.
50. Ha TK, Sattar N, Talwar D, Cooney J, Simpson K, 0'Reilly DS, et al. Abnormal antioxidant vitamin and carotenoid status in chronic renal failure. QJM 1996; 89:765-9.
51. Kanai M, Raz A, Goodman DS. Retinol-binding protein: the transport protein for vitamin A in human plasma. J Clin Invest 1968; 47:2025-44.
52. Mogielnicki RP, Waldmann TA, Strober W. Renal handling of Low molecular weight proteins. I. L-Chain metabolism in experimental renal disease. J Clin Invest 1971; 50: 901-9.
53. Rosales FJ, Ross AC. Acute inflammation induces hyporetinemia and modifies the plasma and tissue response to vitamin A supplementation in marginally vitamin A-deficient rats. J Nutr 1998; 128:960-6.
54. Walston J, Xue Q, Semba RD, Ferrucci L, Cappola AR, Ricks M, et al. Serum antioxidants, inflammation, and total mortality in older women. Am J Epidemiol 2006; 163: 18-26.
55. Watzl B, Kulling SE, Moseneder J, Barth SW, Bub A. A 4-wk intervention with high intake of carotenoid-rich vegetables and fruit reduces plasma C-reactive protein in healthy, nonsmoking men. Am J Clin Nutr 2005; 82: 1052-8.
56. Kimmel PL, Phillips TM, Simmens SJ, Peterson RA, Weihs KL, Alleyne S, et al. Immunologic function and survival in hemodialysis patients. Kidney Int 1998; 54:236-44.
57. Yeum KJ, Booth SL, Sadowski JA, Liu C, Tang G, Krinsky NI, et al. Human plasma carotenoid response to the ingestion of controlled diets high in fruits and vegetables. Am J Clin Nutr 1996; 64:594-602.
58. Nikolakakis N, Kounali D, Tornaritis M, Anastassou A, Papadakis E, Kassotakis G, et al. Adipose tissue fatty acid composition, serum lipids, and serum α-tocopherol in continuous ambulatory peritoneal dialysis patients living on the island of Crete. Perit Dial Int 1999; 19:154-9.
59. Food and Nutrition Board. Vitamin E. In: Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium and Carotenoids. Washington, DC: National Academy Press; 2000:186-283.
60. Mydlik M, Derzsiova K, Racz O, Sipulova A, Boldizsar J, Lovasova E, et al. Vitamin E as an antioxidant agent in CAPD patients. Int J Artif Organs 2002; 25:373-8.
61. Roob JM, Khoschsorur G, Tiran A, Horina JH, Holzer H, Winklhofer-Roob BM. Vitamin Eattenuates oxidative stress induced by intravenous iron in patients on hemodialysis. J Am Soc Nephrol 2000; 11:539-49.
62. Daschner M, Lenhartz H, Botticher D, Schaefer F, Wollschlager M, Mehls 0, et al. Influence of dialysis on plasma lipid preroxidation products and antioxidant levels. Kidney Int 1996; 50:1268-72.